276 related articles for article (PubMed ID: 33636351)
1. Association between renin-angiotensin-aldosterone system inhibitors and risk of dementia: A meta-analysis.
Scotti L; Bassi L; Soranna D; Verde F; Silani V; Torsello A; Parati G; Zambon A
Pharmacol Res; 2021 Apr; 166():105515. PubMed ID: 33636351
[TBL] [Abstract][Full Text] [Related]
2. Renin-angiotensin system blockade use and risks of cognitive decline and dementia: A meta-analysis.
Zhuang S; Wang HF; Li J; Wang HY; Wang X; Xing CM
Neurosci Lett; 2016 Jun; 624():53-61. PubMed ID: 27163195
[TBL] [Abstract][Full Text] [Related]
3. The Divergent Cardiovascular Effects of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Myocardial Infarction and Death.
Strauss MH; Hall AS
Prog Cardiovasc Dis; 2016; 58(5):473-82. PubMed ID: 26586276
[TBL] [Abstract][Full Text] [Related]
4. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis.
Baral R; Tsampasian V; Debski M; Moran B; Garg P; Clark A; Vassiliou VS
JAMA Netw Open; 2021 Mar; 4(3):e213594. PubMed ID: 33787911
[TBL] [Abstract][Full Text] [Related]
5. ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3-5: A Network Meta-Analysis of Randomised Clinical Trials.
Zhang Y; He D; Zhang W; Xing Y; Guo Y; Wang F; Jia J; Yan T; Liu Y; Lin S
Drugs; 2020 Jun; 80(8):797-811. PubMed ID: 32333236
[TBL] [Abstract][Full Text] [Related]
6. Estimation of Renin-Angiotensin-Aldosterone-System (RAAS)-Inhibitor effect on COVID-19 outcome: A Meta-analysis.
Pirola CJ; Sookoian S
J Infect; 2020 Aug; 81(2):276-281. PubMed ID: 32474043
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers reduced dementia risk in patients with diabetes mellitus and hypertension.
Kuan YC; Huang KW; Yen DJ; Hu CJ; Lin CL; Kao CH
Int J Cardiol; 2016 Oct; 220():462-6. PubMed ID: 27390970
[TBL] [Abstract][Full Text] [Related]
8. The divergent protective effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on clinical outcomes of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis.
Xie Q; Tang S; Li Y
Ann Palliat Med; 2022 Apr; 11(4):1253-1263. PubMed ID: 34775774
[TBL] [Abstract][Full Text] [Related]
9. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular events in patients with heart failure: a meta-analysis of randomized controlled trials.
Tai C; Gan T; Zou L; Sun Y; Zhang Y; Chen W; Li J; Zhang J; Xu Y; Lu H; Xu D
BMC Cardiovasc Disord; 2017 Oct; 17(1):257. PubMed ID: 28982370
[TBL] [Abstract][Full Text] [Related]
10. Effect of renin angiotensin blockers on angiotensin converting enzyme 2 level in cardiovascular patients.
Farid Fahmy S; El Derany MO; Khorshid H; Saleh A; El-Demerdash E
BMC Pharmacol Toxicol; 2023 Apr; 24(1):24. PubMed ID: 37060024
[TBL] [Abstract][Full Text] [Related]
11. Effects of renin-angiotensin-aldosterone system inhibitors on disease severity and mortality in patients with COVID-19: A meta-analysis.
Zhang G; Wu Y; Xu R; Du X
J Med Virol; 2021 Apr; 93(4):2287-2300. PubMed ID: 33231299
[TBL] [Abstract][Full Text] [Related]
12. Effects of renin-angiotensin system blockers on renal outcomes and all-cause mortality in patients with diabetic nephropathy: an updated meta-analysis.
Sarafidis PA; Stafylas PC; Kanaki AI; Lasaridis AN
Am J Hypertens; 2008 Aug; 21(8):922-9. PubMed ID: 18535536
[TBL] [Abstract][Full Text] [Related]
13. Renin-Angiotensin-Aldosterone System Inhibitors and Development of Gynecologic Cancers: A 23 Million Individual Population-Based Study.
Nguyen NTH; Nguyen PA; Huang CW; Wang CH; Lin MC; Hsu MH; Bao HB; Chien SC; Yang HC
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835224
[TBL] [Abstract][Full Text] [Related]
14. A Modern History RAAS Inhibition and Beta Blockade for Heart Failure to Underscore the Non-equivalency of ACEIs and ARBs.
Hyman DA; Siebert VR; Birnbaum GD; Alam M; Birnbaum Y
Cardiovasc Drugs Ther; 2020 Apr; 34(2):215-221. PubMed ID: 32219664
[TBL] [Abstract][Full Text] [Related]
15. Renin Angiotensin Blockers and Cardiac Protection: From Basis to Clinical Trials.
Lévy BI; Mourad JJ
Am J Hypertens; 2022 Apr; 35(4):293-302. PubMed ID: 34265036
[TBL] [Abstract][Full Text] [Related]
16. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis.
Cheng J; Zhang W; Zhang X; Han F; Li X; He X; Li Q; Chen J
JAMA Intern Med; 2014 May; 174(5):773-85. PubMed ID: 24687000
[TBL] [Abstract][Full Text] [Related]
17. Renin Angiotensin Aldosterone System Inhibitors in Hypertension: Is There Evidence for Benefit Independent of Blood Pressure Reduction?
Bavishi C; Bangalore S; Messerli FH
Prog Cardiovasc Dis; 2016; 59(3):253-261. PubMed ID: 27777044
[TBL] [Abstract][Full Text] [Related]
18. An umbrella review and meta-analysis of renin-angiotensin system drugs use and COVID-19 outcomes.
Kurdi A; Mueller T; Weir N
Eur J Clin Invest; 2023 Feb; 53(2):e13888. PubMed ID: 36205627
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers therapy and colorectal cancer: a systematic review and meta-analysis.
Dai YN; Wang JH; Zhu JZ; Lin JQ; Yu CH; Li YM
Cancer Causes Control; 2015 Sep; 26(9):1245-55. PubMed ID: 26081426
[TBL] [Abstract][Full Text] [Related]
20. Renin-angiotensin system inhibitors and risk of fractures: a prospective cohort study and meta-analysis of published observational cohort studies.
Kunutsor SK; Blom AW; Whitehouse MR; Kehoe PG; Laukkanen JA
Eur J Epidemiol; 2017 Nov; 32(11):947-959. PubMed ID: 28752198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
